Evidence map›Paper›PMID 26339043›Full record

ArticleJournal of virology2015

Th1/17 Polarization of CD4 T Cells Supports HIV-1 Persistence during Antiretroviral Therapy.

Hong Sun, Dhohyung Kim, Xiaodong Li, Maja Kiselinova, Zhengyu Ouyang, Linos Vandekerckhove, Hong Shang, Eric S Rosenberg, Xu G Yu, Mathias Lichterfeld

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. Persistent, Asymptomatic Colonization withMicrobiology spectrum · 2022
    Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Altered memory CCR6EBioMedicine · 2024
    Article
  16. The Complex Dysregulations of CD4 T Cell Subtypes in HIV Infection.International journal of molecular sciences · 2024
    Review
  17. Article
  18. Review
  19. Review
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Hong SunRagon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA Key Laboratory of AIDS Immunology of the National Health and Family Planning Commission, First Affiliated Hospital of China Medical University, Shenyang, People's Republic of China.
Dhohyung KimRagon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
Xiaodong LiRagon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
Maja KiselinovaRagon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA HIV Translational Research Unit, Ghent University and University Hospital, Ghent, Belgium.
Zhengyu OuyangRagon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
Linos VandekerckhoveHIV Translational Research Unit, Ghent University and University Hospital, Ghent, Belgium.
Hong ShangKey Laboratory of AIDS Immunology of the National Health and Family Planning Commission, First Affiliated Hospital of China Medical University, Shenyang, People's Republic of China.
Eric S RosenbergInfectious Disease Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
Xu G YuRagon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
Mathias LichterfeldRagon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA Infectious Disease Division, Massachusetts General Hospital, Boston, Massachusetts, USA Infectious Disease Division, Brigham and Women's Hospital, Boston, Massachusetts, USA mlichterfeld@partners.org.
Ragon Institute of MGH, MIT and Harvard · USGhent University Hospital · BEChina Medical University · CNMassachusetts General Hospital · USNational Health and Family Planning Commission · CN

Funding

Recognition of HIV-1 by Innate Immunity Receptors during Primary InfectionP01AI074415 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ALLEN, TODD M · 2008 to 2013
$17.3M
Inhibitors of host kinases as molecular targets for immune defense against HIV-1R01AI098487 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LICHTERFELD, MATHIAS · 2012 to 2015
$1.7M
A Microengraving Technology for the Study of Latently HIV-infected Primary CellsR01AI089339 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI YU, XU · 2010 to 2013
$1.6M
Targeting HIV-1 persistence with Interferon-aR33AI116228 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI YU, XU · 2016 to 2018
$1.5M
Targeting HIV-1 persistence with Interferon-aR21AI116228 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI YU, XU · 2014 to 2015
$479k
Limiting HIV-1 persistence by targeting stem cell properties of CD4 T cellsR21AI106468 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI LICHTERFELD, MATHIAS · 2013 to 2014
$465k
NIAID NIH HHS AI074415NIAID NIH HHS AI089339NIAID NIH HHS AI098487NIAID NIH HHS AI106468NIAID NIH HHS AI116228NIAID NIH HHS P01 AI074415NIAID NIH HHS R01 AI089339NIAID NIH HHS R01 AI098487NIAID NIH HHS R21 AI106468NIAID NIH HHS R21 AI116228
6 · The paper itself

Abstract

unlabelledThe ability to persist long term in latently infected CD4 T cells represents a characteristic feature of HIV-1 infection and the predominant barrier to efforts aiming at viral eradication and cure. Yet, increasing evidence suggests that only small subsets of CD4 T cells with specific developmental and maturational profiles are able to effectively support HIV-1 long-term persistence. Here, we analyzed how the functional polarization of CD4 T cells shapes and structures the reservoirs of HIV-1-infected cells. We found that CD4 T cells enriched for a Th1/17 polarization had elevated susceptibilities to HIV-1 infection in ex vivo assays, harbored high levels of HIV-1 DNA in persons treated with antiretroviral therapy, and made a disproportionately increased contribution to the viral reservoir relative to their contribution to the CD4 T memory cell pool. Moreover, HIV-1 DNA levels in Th1/17 cells remained stable over many years of antiretroviral therapy, resulting in a progressively increasing contribution of these cells to the viral reservoir, and phylogenetic studies suggested preferential long-term persistence of identical viral sequences during prolonged antiretroviral treatment in this cell compartment. Together, these data suggest that Th1/17 CD4 T cells represent a preferred site for HIV-1 DNA long-term persistence in patients receiving antiretroviral therapy. IMPORTANCE: Current antiretroviral therapy is very effective in suppressing active HIV-1 replication but does not fully eliminate virally infected cells. The ability of HIV-1 to persist long term despite suppressive antiretroviral combination therapy represents a perplexing aspect of HIV-1 disease pathogenesis, since most HIV-1 target cells are activated, short-lived CD4 T cells. This study suggests that CD4 T helper cells with Th1/17 polarization have a preferential role as a long-term reservoir for HIV-1 infection during antiretroviral therapy, possibly because these cells may imitate some of the functional properties traditionally attributed to stem cells, such as the ability to persist for extremely long periods of time and to repopulate their own pool size through homeostatic self-renewal. These observations support the hypothesis that HIV-1 persistence is driven by small subsets of long-lasting stem cell-like CD4 T cells that may represent particularly promising targets for clinical strategies aiming at HIV-1 eradication and cure.

Indexed as

AdultAnti-HIV AgentsBase SequenceCD4 Lymphocyte CountCell PolarityCells, CulturedDNA, ViralFemaleHIV-1HIV InfectionsHumansMaleMiddle AgedSequence Analysis, DNATh17 CellsTh1 CellsAnti-HIV AgentsDNA, Viral

Identifiers

PMID26339043
PMCPMC4645661
OpenAlexW1749946895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.